0001445499-21-000002.txt : 20210401
0001445499-21-000002.hdr.sgml : 20210401
20210401125038
ACCESSION NUMBER: 0001445499-21-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210401
DATE AS OF CHANGE: 20210401
EFFECTIVENESS DATE: 20210401
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMPEL NEUROPHARMA INC
CENTRAL INDEX KEY: 0001445499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263058238
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-394399
FILM NUMBER: 21797058
BUSINESS ADDRESS:
STREET 1: 201 ELLIOTT AVE. W
STREET 2: SUITE 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
BUSINESS PHONE: 206-568-1466
MAIL ADDRESS:
STREET 1: 201 ELLIOTT AVE. W
STREET 2: SUITE 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
D
1
primary_doc.xml
X0708
D
LIVE
0001445499
IMPEL NEUROPHARMA INC
201 ELLIOTT AVE. W
SUITE 260
SEATTLE
WA
WASHINGTON
98119
206-568-1466
DELAWARE
None
None
Corporation
true
John
D.
Hoekman
c/o Impel NeuroPharma, Inc.
201 Elliott Ave. W, Suite 260
Seattle
WA
WASHINGTON
98119
Executive Officer
Director
Stewart
Parker
c/o Impel NeuroPharma, Inc.
201 Elliott Ave. W, Suite 260
Seattle
WA
WASHINGTON
98119
Director
Aaron
Royston
c/o Impel NeuroPharma, Inc.
201 Elliott Ave. W, Suite 260
Seattle
WA
WASHINGTON
98119
Director
Mahendra
Shah
c/o Impel NeuroPharma, Inc.
201 Elliott Ave. W, Suite 260
Seattle
WA
WASHINGTON
98119
Director
David
Allison
c/o Impel NeuroPharma, Inc.
201 Elliott Ave. W, Suite 260
Seattle
WA
WASHINGTON
98119
Director
Robert
Mittendorff
c/o Impel NeuroPharma, Inc.
201 Elliott Ave. W, Suite 260
Seattle
WA
WASHINGTON
98119
Director
Tim
Nelson
c/o Impel NeuroPharma, Inc.
201 Elliott Ave. W, Suite 260
Seattle
WA
WASHINGTON
98119
Director
Ali
Satvat
c/o Impel NeuroPharma, Inc.
201 Elliott Ave. W, Suite 260
Seattle
WA
WASHINGTON
98119
Director
John
Leaman
c/o Impel NeuroPharma, Inc.
201 Elliott Ave. W, Suite 260
Seattle
WA
WASHINGTON
98119
Executive Officer
Diane
Wilfong
c/o Impel NeuroPharma, Inc.
201 Elliott Ave. W, Suite 260
Seattle
WA
WASHINGTON
98199
Director
Adrian
Adams
c/o Impel NeuroPharma, Inc.
201 Elliott Ave. W, Suite 260
Seattle
WA
WASHINGTON
98199
Executive Officer
Director
Other Health Care
Decline to Disclose
- 06b
false
2021-03-18
false
true
true
false
0
1932000
0
1932000
Represents securities offered under an equity incentive plan.
false
1
0
0
0
false
IMPEL NEUROPHARMA INC
/s/ Adrian Adams
Adrian Adams
President and CEO
2021-04-01